|
Real-time Estimate
Cboe BZX
01:20:26 09/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 23.70 USD | -3.34% |
|
-5.71% | -0.17% |
| 22/09 | Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy | CI |
| 16/09 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Other Biotechnology & Medical Research | -3.06% | -5.71% | -0.17% | +58.07% | -24.43% | 312.22Cr |  | |  |
- Stock Market
- Stocks
- RCUS Stock
- Charts Arcus Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
